Tabbara Marwan, Duque Juan C, Martinez Laisel, Escobar Luis A, Wu Wensong, Pan Yue, Fernandez Natasha, Velazquez Omaida C, Jaimes Edgar A, Salman Loay H, Vazquez-Padron Roberto I
DeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL.
Department of Mathematics and Statistics, Florida International University, Miami, FL.
Am J Kidney Dis. 2016 Sep;68(3):455-64. doi: 10.1053/j.ajkd.2016.02.044. Epub 2016 Mar 22.
The contribution of intimal hyperplasia (IH) to arteriovenous fistula (AVF) failure is uncertain. This observational study assessed the relationship between pre-existing, postoperative, and change in IH over time and AVF outcomes.
Prospective cohort study with longitudinal assessment of IH at the time of AVF creation (pre-existing) and transposition (postoperative). Patients were followed up for up to 3.3 years.
SETTING & PARTICIPANTS: 96 patients from a single center who underwent AVF surgery initially planned as a 2-stage procedure. Veins and AVF samples were collected from 66 and 86 patients, respectively. Matched-pair tissues were available from 56 of these patients.
Pre-existing, postoperative, and change in IH over time.
Anatomic maturation failure was defined as an AVF that never reached a diameter > 6mm. Primary unassisted patency was defined as the time elapsed from the second-stage surgery to the first intervention.
Maximal intimal thickness in veins and AVFs and change in intimal thickness over time.
Pre-existing IH (>0.05mm) was present in 98% of patients. In this group, the median intimal thickness increased 4.40-fold (IQR, 2.17- to 4.94-fold) between AVF creation and transposition. However, this change was not associated with pre-existing thickness (r(2)=0.002; P=0.7). Ten of 96 (10%) AVFs never achieved maturation, whereas 70% of vascular accesses remained patent at the end of the observational period. Postoperative IH was not associated with anatomic maturation failure using univariate logistic regression. Pre-existing, postoperative, and change in IH over time had no effects on primary unassisted patency.
The small number of patients from whom longitudinal tissue samples were available and low incidence of anatomic maturation failure, which decreased the statistical power to find associations between end points and IH.
Pre-existing, postoperative, and change in IH over time were not associated with 2-stage AVF outcomes.
内膜增生(IH)对动静脉内瘘(AVF)失功的作用尚不确定。本观察性研究评估了术前、术后以及IH随时间的变化与AVF结局之间的关系。
前瞻性队列研究,在AVF建立时(术前)和转位时(术后)对IH进行纵向评估。对患者进行了长达3.3年的随访。
来自单一中心的96例患者,最初计划接受两阶段手术的AVF手术。分别从66例和86例患者中采集静脉和AVF样本。其中56例患者可获得配对组织。
术前、术后以及IH随时间的变化。
解剖成熟失败定义为AVF直径从未达到>6mm。初次无辅助通畅定义为从二期手术到首次干预的时间。
静脉和AVF中的最大内膜厚度以及内膜厚度随时间的变化。
98%的患者存在术前IH(>0.05mm)。在该组中,AVF建立和转位之间内膜厚度中位数增加了4.40倍(四分位间距,2.17至4.94倍)。然而,这种变化与术前厚度无关(r²=0.002;P=0.7)。96例AVF中有10例(10%)从未实现成熟,而70%的血管通路在观察期结束时仍保持通畅。使用单因素逻辑回归分析,术后IH与解剖成熟失败无关。术前、术后以及IH随时间的变化对初次无辅助通畅无影响。
可获得纵向组织样本的患者数量较少,且解剖成熟失败的发生率较低,这降低了发现终点与IH之间关联的统计效力。
术前、术后以及IH随时间的变化与两阶段AVF结局无关。